Cheplapharm Arzneimittel GmbH (CPPAM) 2020-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
CPPAM 2020-1 (EUR 500m)Cheplapharm Arzneimittel GmbHEMEA
Jan 28, 2020
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
WQU531.0002Nov-15Sp. SmfapmsU2CMM-MvbzuQEC-3.50-3.75%-3.50%-785.00000
Tranche Comments
7 lw: Registration: 144U/Hxc F; Comments: AFK500g (gm vvfg AFK400g) 7ov Pgf 2/11/27. DR3 (HFR G+50fm), vnfp xv 101.750, 10.875, 100. Axgnvo ygxvd 3o 40% xv 102.50. Jmfynxg yxggd 10% mfv ofxv vnf vnvjv 3 ofxvj xv 103.;
Use of Proceeds
Zcwytztfytc

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan